COA At-a-Glance
Evidence of cognitive interviewing of draft instrument in target patient population
Evidence of internal consistency
Evidence of test-retest or inter-rater reliability
Evidence of concurrent validity
Evidence of known-groups validity
Evidence of ability to detect change over time
Evidence of responder thresholds
Inclusion of the COA in product labelling
- Overview
- Content Validity
- Reliability
- Validity
- Ability to Detect Change
- Responder Thresholds
- Reference(s) of development / validation
- Other references
- Inclusion of the COA in product labelling
- Existence of Scoring / Interpretation / User Manual
- Original language and translations
- References of translations
- Authors and contact information
- Condition of use: copyright
- Website
- Review copy
Overview
Instrument Name: MacArthur-Communication Development Inventories-Infant Short Form
Abbreviation: MacArthur-CDI-Infant SF
Points for Consideration:
Tracking vocab growth (and loss) is a powerful means of determining language change; however, the categories could potentially have cultural bias (all cultures may not acquire the same vocabulary in the same sequence, if at all). Limited information on development or testing of short form.
Description of Tool:
The MacArthur-Communication Development Inventories-Infant Short Form is an ObsRO developed to measure language growth in children aged 8 to 18 months (All, Language Development Disorders).
Other Related Tools (if applicable):
MacArthur-Bates Communication Development Inventory III; Short form for Toddlers (16- to 30-month-olds)
Minimum Qualification Required by COA Administrator: No degree requirement
Comment:
Developed from the MacArthur-Bates Communication Development Inventories
Year: 2000
Objective of Development:
To measure language growth in children with and without disabilities
Population of Development: Age range (therapeutic indication):
8 to 18 months (All, Language Development Disorders)
Pediatric Population(s) in which COA has been used:
MB-CDI: Mental Disorders; Female Urogenital Diseases and Pregnancy Complications; Otorhinolaryngologic Diseases; Nervous System Diseases; Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Infections; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases; Musculoskeletal Diseases; Stomatognathic Diseases; Chemically-Induced Disorders
COA type:
Number of Items 89
Mode of Administration:
Data Collection Mode:
Time for Completion: None identified
Response Scales: Dichotomous: Understand / Understand and says
Summary of Scoring:
Available Scores:
Global score: Raw score converted in percentile
Weighting:
No
Score Direction:
Higher score = Better communicative skills
Content Validity
Evidence of Literature Review: None identified
Evidence of Instrument Review: Yes
Evidence of Clinical or Expert Input: Yes
Evidence of concept elicitation in target patient population: None identified
Evidence of a Saturation Grid: None identified
Evidence for Selection of Data Collection Method: None identified
Recall/Observation Period:
Evidence for Selection of Reponse Options: None identified
Evidence of cognitive interviewing of draft instrument in target patient population: None identified
Evidence of Preliminary Scoring of Items and Domains: Yes
Evidence related to respondent and administrator burden: None identified
Evidence of a Conceptual Framework: None identified
Evidence of an item-tracking matrix: None identified
Evidence related to item selection: None identified
Evidence of re-testing the final version: None identified
Reliability
Internal consistency (Cronbach's alpha): Yes
Evidence of internal consistency:
Evidence of test-retest or inter-rater reliability: None identified
Validity
Concurrent validity (convergent, divergent):
None identified
Known-group validity:
None identified
Evidence of Translatability Assessment: None identified
Evidence related to missing data: None identified
Evidence for Selection of Recall Period: None identified
Evidence of Administration Instructions and Training Provided: None identified
Evidence of concurrent validity: None identified
Evidence of known-groups validity: None identified
Evidence of ability to detect change over time: None identified
Ability to Detect Change
Ability to detect change (Responsiveness):
None identified
Responder Thresholds
Responder Thresholds:
None identified
Evidence of responder thresholds: None identified
Reference(s) of development / validation
Fenson L, Pethick S, Renda C, Cox JL, Dale PS, Reznick JS. Short-form versions of the MacArthur Communicative Development Inventories. Applied Psycholinguistics 21, Cambridge University Press. 2000; 95–116
Abstract: https://psycnet.apa.org/record/2000-08387-005
MacArthur Bates CDI website
https://mb-cdi.stanford.edu/about.html
Other references
See (PubMed results)
https://pubmed.ncbi.nlm.nih.gov/?term=%22MacArthur+Communicative+Development+Inventories%22+AND+%22SHORT%22&sort=date&sort_order=asc
Inclusion of the COA in product labelling
None identified
Existence of Scoring / Interpretation / User Manual
Original language and translations
Original: English for the USA
Translations:
Finnish for Finland
Portuguese for Portugal
Spanish
Czech
References of translations
Finnish for Finland
Stolt S, Vehkavuori S-M. Sanaseula. The Finnish short form versions of the MacArthur Communicative Development Inventories. 2018 (Abstract: https://www.researchgate.net/publication/324721718_Sanaseula_The_Finnish_short_form_versions_of_the_MacArthur_Communicative_Development_Inventories)
Vehkavuori S-M, Stolt S. Screening language skills at 2;0. Infant Behavior and Development. 2018 50, 174-179 (PubMed abstract: https://pubmed.ncbi.nlm.nih.gov/29407426/)
Copy of the Spanish translation can be obtained here: https://mb-cdi.stanford.edu/forms.html
For more information on adaptations and translations of the MB-CDI see here: https://mb-cdi.stanford.edu/adaptations.html
Condition of use: copyright
Copyright:
CDI Advisory Board holds the copyright
CoU:
*With fees for academic/non profit research
*With fees for commercial/pharmaceutical companies
*For further information and details on purchasing the MacArthur-CDI-Infant SF, please contact directly Larry Fenson
Website
MacArthur Bates CDI website: https://mb-cdi.stanford.edu/about.html
Review copy
MacArthur-CDI-Infant SF available in Fenson et al. 2000